Qiagen diagnostic news

Qiagen said it will close its site in Gaithersburg, Md., by early 2015 and move activities to its facilities in Germantown, Md. The company also said it will invest an additional $10 million to upgrade its facilities in Frederick, Md., and Germantown, which will become the manufacturing site for some of its highest-volume diagnostic assays, including the Digene HC2 HPV DNA test, an HPV-based cervical cancer screening test. The company also plans to move manufacturing to Germantown for its QuantiFERON-TB Gold test for latent tuberculosis. ...